VivoSeq
Infectious Disease

Plasmodium Vivax Infection

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Plasmodium Vivax Infection is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Completed2 · 50%
Unknown status2 · 50%

Clinical Trials

Trial Activity

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection
Completed·OOswaldo Cruz Foundation·Phase 2/3·NCT02691910·204 enrolled
Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
Unknown status·PPapua New Guinea Institute of Medical Research·Phase 4·NCT02364583·150 enrolled
Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam
Unknown status·National Institute of Malariology, Parasitology and Entomology, Vietnam·Phase 4·NCT02610686·100 enrolled
A Clinical Study to Assess the Feasibility of a Controlled Human Plasmodium Vivax Malaria Infection Model Through Sporozoite Infection in Thai Adults
Completed·UUniversity of Oxford·Preclinical·NCT04083508·5 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)